Broccoli turns into an anti diabetes fighter

Green vegetables are regarded as the representative of healthy food, which often appear on the list of food recommended by doctors and nutritionists Scientists have found that powder containing broccoli extract can reduce blood sugar concentration of type 2 diabetes patients by about 10% The new findings will provide a new choice for type 2 diabetes patients to control their blood sugar Early studies have found that sulforaphane, which is contained in Cruciferae Plants, can reduce blood glucose levels in diabetic mice Anders Rosengren and his team from the University of Gothenburg in Sweden recruited 97 volunteers with type 2 diabetes to study whether sulforaphane has the same effect on the human body The volunteers in the experimental group were required to take a concentrated sulforaphane powder at a dose of about 100 times the content of natural broccoli every day, "which is equivalent to eating 5 kg of broccoli every day," Rosengren said The researchers also set up a daily placebo control group In addition, three of all continued to take metformin, a hypoglycemic drug The results showed that the blood glucose of the volunteers taking broccoli extract decreased by an average of 10% compared with the control group taking placebo Although they didn't take hypoglycemic drugs, their blood sugar was well controlled, especially in the obese 5 kg broccoli to lower blood sugar! Source: further study by Adam Gault / Getty team found that sulforaphane and metformin reduce blood sugar in different ways Metformin can make cells more sensitive to insulin, reduce insulin resistance, and then absorb excess glucose in blood vessels Metformin has a significant hypoglycemic effect, but there is a risk of kidney damage, so 15% of patients are not suitable for this drug Sulforaphane reduces blood sugar by inhibiting liver enzymes that stimulate glucose production Therefore, Rosengren believes that sulforaphane plays a more competitive role than a supplement to metformin Sulforaphane will be an ideal alternative to metformin in patients with renal dysfunction More experiments are needed to verify the reliability of sulforaphane, the researchers said Meanwhile, Rosengren and his colleagues are applying to the relevant departments for approval of sulforaphane powder, which is expected to be approved within two years.